Literature DB >> 6411171

Congenital toxoplasmosis in England, Wales, and Northern Ireland: some epidemiological problems.

S M Hall.   

Abstract

It has been suggested that congenital toxoplasmosis could be prevented by antenatal serological screening, followed by treatment or by termination of pregnancy if infection occurs. The only study of the incidence of congenital toxoplasmosis in England, Wales, and Northern Ireland took place more than 10 years ago. To obtain more recent figures laboratory reports of cases occurring from 1975 to 1980 were analysed. A total of 91 cases were reported over the six years. By criteria established to classify these infections only 34 were congenital, 20 were acquired postnatally, and 37 were unclassifiable. The mean annual number of cases of congenital toxoplasmosis was considerably smaller than that found in other recent studies. The condition could be underdiagnosed or rates of placental transmission could be lower in Britain than in other countries. Variation in reporting criteria of the laboratories made the data difficult to interpret. Improved diagnosis of congenital toxoplasmosis would not only clarify the epidemiology but would also help clinicians in management of suspected cases. Further antenatal surveys are necessary to assess the role of screening in the prevention of congenital toxoplasmosis.

Entities:  

Mesh:

Year:  1983        PMID: 6411171      PMCID: PMC1548718          DOI: 10.1136/bmj.287.6390.453

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

Review 1.  Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease.

Authors:  C A Alford; S Stagno; D W Reynolds
Journal:  Bull N Y Acad Med       Date:  1974-02

2.  Toxoplasmosis in pregnancy.

Authors:  C F Ruoss; G L Bourne
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-12

3.  Screening for toxoplasmosis in pregnancy.

Authors:  E J Broadbent; R Ross; R Hurley
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

4.  Congenital toxoplasmosis: a prospective survey in the West of Scotland.

Authors:  K A Williams; J M Scott; D E Macfarlane; J M Williamson; T F Elias-Jones; H Williams
Journal:  J Infect       Date:  1981-09       Impact factor: 6.072

5.  Enzyme-linked immunosorbent assay (ELISA) using antibody class capture for the detection of antitoxoplasma IgM.

Authors:  R A Payne; M Isaac; J M Francis
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

6.  Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.

Authors:  C B Wilson; J S Remington; S Stagno; D W Reynolds
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

7.  Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections.

Authors:  G Desmonts; Y Naot; J S Remington
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

8.  What can be done to prevent congenital toxoplasmosis?

Authors:  C B Wilson; J S Remington
Journal:  Am J Obstet Gynecol       Date:  1980-10-15       Impact factor: 8.661

  8 in total
  8 in total

1.  Congenital toxoplasmosis.

Authors:  D O Ho-Yen; A W Joss; J M Chatterton
Journal:  BMJ       Date:  1992-09-12

Review 2.  Congenital toxoplasmosis.

Authors:  S M Hall
Journal:  BMJ       Date:  1992-08-01

3.  The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis.

Authors:  A O Carter; S B Gelmon; G A Wells; A P Toepell
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

4.  A treatable cause of hydrops fetalis.

Authors:  H P Roper
Journal:  J R Soc Med       Date:  1986-02       Impact factor: 5.344

Review 5.  The TORCH screen and intrauterine infections.

Authors:  A Greenough
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-05       Impact factor: 5.747

Review 6.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

7.  Longitudinal study of Toxoplasma seroprevalence in South Yorkshire.

Authors:  J Walker; D J Nokes; R Jennings
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

Review 8.  Cerebral palsy--an increasing contributor to severe mental retardation?

Authors:  A Nicholson; E Alberman
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.